Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Mei Pharma, Inc. (MSHL) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Mei Pharma, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1262104.
Total stock buying since 2014: $2,392,787.
Total stock sales since 2014: $4,556,316.
Total stock option exercises since 2014: $62,840.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 417,600 | $2,130,933 | 0 | $0 | 0 | $0 |
| 2021 | 0 | $0 | 25,000 | $100,625 | 5,000 | $12,600 |
| 2020 | 0 | $0 | 0 | $0 | 12,000 | $18,840 |
| 2019 | 118,750 | $192,070 | 0 | $0 | 20,000 | $31,400 |
| 2018 | 0 | $0 | 9,500 | $34,048 | 0 | $0 |
| 2017 | 11,000 | $24,805 | 11,000 | $24,277 | 0 | $0 |
| 2015 | 5,000 | $19,050 | 2,014,655 | $3,921,758 | 0 | $0 |
| 2014 | 5,000 | $25,929 | 79,085 | $475,608 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-09 | 336,100 | $2,112,596 | 0 | $0 | 0 | $0 |
| 2023-02 | 81,500 | $18,337 | 0 | $0 | 0 | $0 |
| 2021-05 | 0 | $0 | 0 | $0 | 5,000 | $12,600 |
| 2021-02 | 0 | $0 | 25,000 | $100,625 | 0 | $0 |
| 2020-07 | 0 | $0 | 0 | $0 | 12,000 | $18,840 |
| 2019-12 | 103,750 | $166,000 | 0 | $0 | 0 | $0 |
| 2019-09 | 15,000 | $26,070 | 0 | $0 | 20,000 | $31,400 |
| 2018-08 | 0 | $0 | 9,500 | $34,048 | 0 | $0 |
| 2017-11 | 11,000 | $24,805 | 11,000 | $24,277 | 0 | $0 |
| 2015-11 | 0 | $0 | 413,265 | $762,216 | 0 | $0 |
| 2015-03 | 0 | $0 | 1,601,390 | $3,159,542 | 0 | $0 |
| 2015-01 | 5,000 | $19,050 | 0 | $0 | 0 | $0 |
| 2014-12 | 3,000 | $12,809 | 79,085 | $475,608 | 0 | $0 |
| 2014-06 | 2,000 | $13,120 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-09-22 | Ma-weaver Jacob | Buy | 32,040 | 6.85 | 219,570 |
| 2023-09-22 | Winson Bruce Ross | Buy | 48,060 | 6.85 | 329,355 |
| 2023-09-21 | Ma-weaver Jacob | Buy | 22,400 | 6.46 | 144,748 |
| 2023-09-21 | Winson Bruce Ross | Buy | 33,600 | 6.46 | 217,123 |
| 2023-09-20 | Ma-weaver Jacob | Buy | 80,000 | 6.01 | 480,720 |
| 2023-09-20 | Winson Bruce Ross | Buy | 120,000 | 6.01 | 721,080 |
| 2023-02-28 | Baltic Charles V. Iii (Director) | Buy | 81,500 | .23 | 18,337 |
| 2021-05-25 | Gold Daniel P Phd (Chief Executive Officer) | Option Ex | 5,000 | 2.52 | 12,600 |
| 2021-02-23 | Driscoll Frederick W (Director) | Sale | 25,000 | 4.03 | 100,625 |
| 2020-07-23 | Gold Daniel P Phd (Chief Executive Officer) | Option Ex | 12,000 | 1.57 | 18,840 |
| 2019-12-19 | Drazba Brian G. (Chief Financial Officer) | Buy | 12,500 | 1.60 | 20,000 |
| 2019-12-19 | Reynolds Thomas C (Director) | Buy | 10,000 | 1.60 | 16,000 |
| 2019-12-19 | Gold Daniel P Phd (Chief Executive Officer) | Buy | 18,750 | 1.60 | 30,000 |
| 2019-12-19 | Driscoll Frederick W (Director) | Buy | 62,500 | 1.60 | 100,000 |
| 2019-09-27 | Gold Daniel P Phd (Chief Executive Officer) | Option Ex | 20,000 | 1.57 | 31,400 |
| 2019-09-06 | White Christine Anna (Director) | Buy | 15,000 | 1.74 | 26,070 |
| 2018-08-07 | Urso David M (Chief Operating Officer & GC) | Sale | 9,500 | 3.58 | 34,048 |
| 2017-11-27 | Baltic Charles V. Iii (Director) | Buy | 11,000 | 2.25 | 24,805 |
| 2017-11-27 | Baltic Charles V. Iii (Director) | Sale | 11,000 | 2.21 | 24,277 |
| 2015-11-09 | Vivo Ventures Vii, Llc (10% Owner) | Sale | 157,352 | 1.75 | 275,366 |
| 2015-11-09 | Vivo Ventures V, Llc (10% Owner) | Sale | 9,142 | 1.75 | 15,998 |
| 2015-11-06 | Vivo Ventures Vii, Llc (10% Owner) | Sale | 7,560 | 1.85 | 13,986 |
| 2015-11-06 | Vivo Ventures V, Llc (10% Owner) | Sale | 440 | 1.85 | 814 |
| 2015-11-05 | Vivo Ventures Vii, Llc (10% Owner) | Sale | 225,660 | 1.91 | 431,010 |
| 2015-11-05 | Vivo Ventures V, Llc (10% Owner) | Sale | 13,111 | 1.91 | 25,042 |
| 2015-03-24 | Ratcliffe Liam (10% Owner) | Sale | 1,601,390 | 1.97 | 3,159,542 |
| 2015-01-21 | Baltic Charles V. Iii (Director) | Buy | 5,000 | 3.81 | 19,050 |
| 2014-12-31 | Baltic Charles V. Iii (Director) | Buy | 3,000 | 4.27 | 12,809 |
| 2014-12-09 | Ratcliffe Liam (10% Owner) | Sale | 70,081 | 6.01 | 421,116 |
| 2014-12-08 | Ratcliffe Liam (10% Owner) | Sale | 9,004 | 6.05 | 54,492 |
| 2014-06-30 | Baltic Charles V. Iii (Director) | Buy | 2,000 | 6.56 | 13,120 |
Insider trading activities including stock purchases, stock sales, and option exercises of MSHL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Mei Pharma, Inc. (symbol MSHL, CIK number 1262104) see the Securities and Exchange Commission (SEC) website.